Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Phase 1/2 vaccine trial against the Middle East Respiratory Syndrome (MERS) will begin this ...
CALGARY, Alberta and SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...
Results from the ACTIVExtend trial, which demonstrated statistically significant fracture risk reduction at 3.5 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email